// App-Quantinova.ai

BSH19‐PO‐018 : Differential response to Src inhibition across AML cell lines gives insight on potential patient stratification for therapy

Researchers

Presenter

  • A. Gonzlez-Snchez

Principal Investigators

  • D. Venney

  • K. Mills

Medical Centers

  • Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • saracatinib

  • dasatinib

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved